Top Markets
Coin of the day
MetaStat Inc MetaStat Inc

MetaStat Inc

MTST
Hisse Senetlerindeki Sıralama #42020
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Hisse Fiyatı
$0.001
Son senkronizasyon: 2026-08-11
Piyasa Değeri
$5.88K
Değişim (1 gün)
0.00%
Değişim (1 yıl)
400.00%
Ülke
US
Ticaret MetaStat Inc (MTST)

Kategori

MetaStat Inc (MTST) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.00 - 2026-08-01

Gün sonu en düşük fiyat: $8.64K - 2009-01-01
MetaStat Inc için hisse fiyatı geçmişi: 2009 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 0.00%
2025 463.64%
2024 0.00%
2023 0.00%
2022 -94.49%
2021 -97.16%
2020 -66.02%
2019 -80.17%
2018 -86.53%
2017 -59.23%
2016 -66.02%
2015 -30.12%
2014 -67.24%
2013 -59.82%
2012 145.63%
2011 -91.79%
2010 111.42%
2009 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$57.26 50.14%
CN
$108.57 62.31%
CH
$460.07 28.69%
IE
$287.89 109.53%
US
$8.79 84.34%
TH